Home
 /
Papers
 /
Synthetic Biology
 /
De novo design of metalloproteases for targeted amyloid-β cleavage
Preprint
Open access
V1
Top 1% · Validated by QED

De novo design of metalloproteases for targeted amyloid-β cleavage

Yannan Qu, Chentong Wang, Hongli Zhu +2 more
March 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.01.06.697903
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Synthetic Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

Establishing that computational design delivers sequence-specific proteases with >10^7-fold rate acceleration and cryo-EM-confirmed precision, this work overturns the field's long-standing ceiling on de novo enzyme design and makes programmable peptide-bond cleavage a genuine engineering capability.

QED claims analysis

Summary

Flow-based generative modeling enables de novo design of sequence-specific zinc metalloproteases that achieve precise cleavage of amyloid-β peptide at predetermined sites with >10^7-fold catalytic rate enhancement, validated by cryo-EM structures showing high fidelity to computational models (RMSD 1.13-1.88 Å) and demonstrating programmable proteolysis of disease-relevant substrates.

See full analysis
Main Claim 1 –

Proteus2 Two-Step Encapsulation Co-Generates Protease–Substrate Complexes

Main Claim 2 –

De Novo Metalloproteases Precisely Cleave Intended Amyloid-β Sites

Supporting evidence

  • Catalytic Glutamate Is Essential; Oxyanion Hole Tunes Activity
  • PP507-S1 Shows Exclusive Cleavage of Its Cognate Substrate
  • Protease Cocktails Enable Site-Specific Hydrolysis of Full-Length Aβ42
  • Mass Spectrometry Validates Cleavage Products Match Predicted Sites
Main Claim 3 –

Designed Metalloproteases Achieve >10^7-Fold Peptide Hydrolysis Acceleration

Supporting evidence

  • DP622-S2 Is Most Efficient, Completing Substrate Digestion in 4 Hours
  • Single Active-Site Mutations Boost Efficiency Mainly by Increasing kcat
Main Claim 4 –

Cryo-EM Confirms Designed Protease Structures Match Models (1.13–1.88 Å)

Abstract

De novo protein design has not yet achieved the creation of proteases capable of selectively cleaving any desired peptide bond within a native protein with high precision. Here, we report the use of the flow-based generative model Proteus2 to design metalloproteases by generating enzyme–substrate complexes conditioned on a target peptide sequence and a predefined catalytic motif. Our approach employs a two-step encapsulation strategy to create clamp-like metalloproteases that bind the target peptide in a manner that maximizes substrate sequence specificity. The generative process simultaneously optimizes the precise positioning of the target peptide bond in a catalytically competent configuration and accurately scaffolds the transition state catalytic residues—both essential for specific and efficient catalysis. Using this strategy, we designed zinc metalloproteases targeting three distinct cleavage sites within the aggregation-prone regions of amyloid-β (Aβ), a key pathogenic factor in Alzheimer’s disease. Experimental characterization validated five enzymes, each capable of precise cleavage at the intended sites with high specificity and minimal or undetectable activity on non-cognate substrates. On average, these enzymes accelerated peptide bond hydrolysis by more than 107-fold relative to the uncatalyzed reaction, and enabled efficient digestion of the Aβ peptide into smaller segments when enzymes targeting different sites were combined. Cryo-EM structures of three designed enzymes in complex with Aβ peptide, each targeting a distinct cleavage site, revealed close agreement with the design models. Together, these results demonstrate the potential of sequence-guided, generative approaches for developing programmable, sequence-specific proteolysis and lay the groundwork for future applications in basic research and therapeutic development.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?